Cocrystal Pharma
COCP
#9720
Rank
HK$0.17 B
Marketcap
HK$17.48
Share price
7.14%
Change (1 day)
18.44%
Change (1 year)

P/E ratio for Cocrystal Pharma (COCP)

P/E ratio as of December 2024 (TTM): -0.9803

According to Cocrystal Pharma 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.980349. At the end of 2022 the company had a P/E ratio of -0.4097.

P/E ratio history for Cocrystal Pharma from 2012 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.4097-99.16%
2021-48.8545.22%
2020-7.562181.78%
2019-0.3311-83.9%
2018-2.06-98.97%
2017-2005701.85%
2016-3.45-67.9%
2015-10.7-51.89%
2014-22.384.43%
2013-12.1-50.61%
2012-24.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
54.4-5,649.07%๐Ÿ‡บ๐Ÿ‡ธ USA
11.0-1,217.27%๐Ÿ‡บ๐Ÿ‡ธ USA
10.3-1,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
53.6-5,571.29%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.